• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025

    2/25/25 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SNDL alert in real time by email

    CALGARY, AB, Feb. 25, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2024 financial results for the period ended December 31, 2024, before market opens on Tuesday, March 18, 2025.

    SNDL Inc Logo (CNW Group/SNDL Inc.)

    Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 18, 2025.

    WEBCAST ACCESS

    To access the live webcast of the call, please visit the following link:

    https://edge.media-server.com/mmc/p/yxxmbsby

    ABOUT SNDL INC. 

    SNDL is a public company whose shares are traded on the Nasdaq under the symbol "SNDL." SNDL is the largest private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Firesale Cannabis. SNDL is a licensed cannabis producer and one of the largest vertically integrated cannabis companies in Canada specializing in low-cost biomass sourcing, premium indoor cultivation, product innovation, low-cost manufacturing facilities, and a cannabis brand portfolio that includes Top Leaf, Contraband, Palmetto, Bon Jak, Versus, Value Buds, No Future, Pearls, and Vacay. SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry. For more information on SNDL, please go to https://sndl.com/. 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sndl-to-announce-fourth-quarter-2024-and-full-year-2024-financial-results-on-march-18-2025-302384992.html

    SOURCE SNDL Inc.

    Get the next $SNDL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNDL

    DatePrice TargetRatingAnalyst
    7/17/2024Speculative Buy
    Canaccord Genuity
    8/16/2022$5.00Hold → Speculative Buy
    Canaccord Genuity
    5/3/2022$0.60 → $0.70Underperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $SNDL
    SEC Filings

    See more
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      5/1/25 7:21:29 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      4/30/25 7:55:52 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      4/22/25 7:32:45 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SNDL Reports First Quarter 2025 Financial and Operational Results

      The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure EDMONTON, AB, May 1, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference cal

      5/1/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Launches Rise Rewards Loyalty Program

      EDMONTON, AB, April 22, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") is excited to announce the launch of its highly anticipated Rise Rewards loyalty program, designed to help Value Buds customers save more, earn more, and get even more from every visit. Starting April 22, 2025, Rise Rewards will be available at all Value Buds locations in Alberta, Ontario, Saskatchewan, and Manitoba. "Our vision is always focused on the consumer experience, and our Rise Rewards program is an exciting tool to provide even more value for the Value Buds shoppe

      4/22/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL to Announce First Quarter 2025 Financial Results on May 1, 2025

      EDMONTON, AB, April 14, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2025 financial results for the period ended March 31, 2025, before market opens on Thursday, May 1, 2025. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on May 1, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/4ikuz377 ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), th

      4/14/25 4:30:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Financials

    Live finance-specific insights

    See more

    $SNDL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SNDL Reports First Quarter 2025 Financial and Operational Results

      The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure EDMONTON, AB, May 1, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference cal

      5/1/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL to Announce First Quarter 2025 Financial Results on May 1, 2025

      EDMONTON, AB, April 14, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2025 financial results for the period ended March 31, 2025, before market opens on Thursday, May 1, 2025. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on May 1, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/4ikuz377 ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), th

      4/14/25 4:30:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

      The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow  CALGARY, AB, March 18, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation and shareholder letter on its website, found at https://sndl.com. The Co

      3/18/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canaccord Genuity resumed coverage on SNDL Inc.

      Canaccord Genuity resumed coverage of SNDL Inc. with a rating of Speculative Buy

      7/17/24 12:19:57 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Sundial Growers upgraded by Canaccord Genuity with a new price target

      Canaccord Genuity upgraded Sundial Growers from Hold to Speculative Buy and set a new price target of $5.00

      8/16/22 7:59:34 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Sundial Growers upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Sundial Growers from Underperform to Market Perform and set a new price target of $0.70 from $0.60 previously

      5/3/22 7:19:03 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Leadership Updates

    Live Leadership Updates

    See more
    • SNDL Appoints New Chief Information Officer and New President, Liquor Division

      CALGARY, AB, Nov. 21, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. "SNDL's success is driven by our commitment to talent density and our leaders are the foundation of our performance culture," said Zach George, Chief Executive Officer of SNDL.  "Phil's extensive expertise in technology and digital innovation, paired with Nav's financial acumen and best-in-class retail experience will further strengthen our executio

      11/21/24 6:02:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Announces 2024 Annual General Meeting Results

      CALGARY, AB, July 30, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders of common shares (the "Shareholders") at the Annual General Meeting (the "Meeting") were passed. At the Meeting, Shareholders approved: (i) fixing the number of directors of the board at six (6); (ii) electing each of Gregory Mills, Zachary George, Lori Ell, Frank Krasovec, Bryan Pinney and Gregory Turnbull as directors of the Company for the ensuing year; and (iii) re-appointing Marcum LLP as the auditors of the Company for the ensu

      7/30/24 5:45:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Skymint Assets Acquired from Receivership; Sunstream USA Builds on Parallel Acquisition

      CALGARY, AB, Oct. 13, 2023 /PRNewswire/ - SunStream Bancorp Inc. ("SunStream") is pleased to announce a receivership court order (the "Sale Order") granting the sale of certain assets of Greenpeak Industries Inc. and certain affiliated entities d.b.a. Skymint ("Skymint") to Skymint Acquisition Co. (the "Skymint Transaction"), a newly formed designee entity of Tropics LP ("Tropics"). Tropics is a limited partnership fully owned by an affiliate of Sunstream, a joint venture sponsored by SNDL Inc. (NASDAQ:SNDL) ("SNDL").  Skymint Acquisition Co. is anticipated to be part of the S

      10/13/23 8:37:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Filed by)

      1/31/24 4:48:48 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Subject)

      2/14/23 5:28:02 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Filed by)

      2/13/23 4:06:09 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care